losartan has been researched along with Fistula in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sykora, M | 1 |
| Kratky, V | 1 |
| Cervenka, L | 1 |
| Kopkan, L | 1 |
| Tribulova, N | 1 |
| Szeiffova Bacova, B | 1 |
1 other study available for losartan and Fistula
| Article | Year |
|---|---|
The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats.
Topics: Animals; Blood Pressure; Connexin 43; Extracellular Matrix; Fistula; Heart Failure; Hypertension; Lo | 2023 |